Mohammad Goodarzi

1.4k citations
16 papers · 1.1k indexed · h-index 10
Topics
Extracellular vesicles in disease (3 papers)MicroRNA in disease regulation (3 papers)Sirtuins and Resveratrol in Medicine (2 papers)
Partner nations
IranUnited StatesBelgium

In The Last Decade

Mohammad Goodarzi

16 papers receiving 1.1k citations

Peers

Mohammad Goodarzi
Comparison fields: 5 of 95
  • Molecular Biology 721
  • Cancer Research 422
  • Physiology 176
  • Immunology 114
  • Pathology and Forensic Medicine 92
Replace Gang Du with:
Gang Du China
Wei Han China
Caiping Chen China
Maryam Peymani Iran
Ki-Sun Kwon South Korea
Wei Dong China
Chul Won Yun South Korea
Hyemin Lee South Korea
Chia-Chen Chen Taiwan
Mohammad Goodarzi relative to Gang Du China Gang Du's profile →
Citations per field
00.5×3.4×
Gang Du · 1×
Citations per year

Countries citing papers authored by Mohammad Goodarzi

Since Specialization
Citations

This map shows the geographic impact of Mohammad Goodarzi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mohammad Goodarzi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mohammad Goodarzi more than expected).

Fields of papers citing papers by Mohammad Goodarzi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mohammad Goodarzi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mohammad Goodarzi. The network helps show where Mohammad Goodarzi may publish in the future.

Co-authorship network of co-authors of Mohammad Goodarzi

This figure shows the co-authorship network connecting the top 25 collaborators of Mohammad Goodarzi. A scholar is included among the top collaborators of Mohammad Goodarzi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mohammad Goodarzi. Mohammad Goodarzi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

16 of 16 papers shown
#WorkIndexed citations
1 5
2 4
3 3
4 9
5 8
6 6
7 15
8 43
9 21
10 168
11 168
12 165
13 102
14 72
15 138
16 201

About Mohammad Goodarzi

Mohammad Goodarzi is a scholar working on Aging, Geriatrics and Gerontology and Molecular Medicine, having authored 16 papers that have together received 1.1k indexed citations. Recurring topics across this work include Extracellular vesicles in disease (3 papers), MicroRNA in disease regulation (3 papers) and Sirtuins and Resveratrol in Medicine (2 papers). The work is most often cited by research in Cancer Research (422 citations), Aging (44 citations) and Molecular Biology (721 citations). Mohammad Goodarzi has collaborated with scholars based in Iran, United States and Belgium. Frequent co-authors include Hamed Mirzaei, Aria Masoudifar, Mahmoud Reza Jaafari, Hamid Reza Mirzaei, Amirhossein Sahebkar, Leila Saadatpour, Bahman Rashidi, Hamid Mirzaei, Fatemeh Momeni and Reyhaneh Nassiri Mansour. Their work appears in journals such as Journal of Clinical Investigation, Nature Communications and Circulation Research.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026